Beryllium granuloma: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:Granuloma.jpg|thumb|Granuloma.jpg]] '''Beryllium granuloma''' is a type of [[granuloma]] that forms in response to exposure to [[beryllium]], a chemical element with the symbol Be and atomic number 4. This condition is a manifestation of [[berylliosis]], also known as chronic beryllium disease (CBD), which is a chronic allergic-type lung response and chronic lung disease caused by exposure to beryllium and its compounds. | {{SI}} | ||
{{Infobox medical condition | |||
| name = Beryllium granuloma | |||
| image = [[File:Granuloma.jpg|250px]] | |||
| caption = Histological image of a beryllium granuloma | |||
| field = [[Pulmonology]], [[Immunology]] | |||
| symptoms = [[Cough]], [[shortness of breath]], [[fatigue]] | |||
| complications = [[Chronic beryllium disease]], [[pulmonary fibrosis]] | |||
| onset = Variable, often years after exposure | |||
| duration = Chronic | |||
| causes = Exposure to [[beryllium]] | |||
| risks = Occupational exposure in industries such as [[aerospace]], [[nuclear power]], and [[electronics]] | |||
| diagnosis = [[Chest X-ray]], [[CT scan]], [[lung biopsy]], [[beryllium lymphocyte proliferation test]] | |||
| differential = [[Sarcoidosis]], [[tuberculosis]], [[hypersensitivity pneumonitis]] | |||
| prevention = Avoidance of beryllium exposure, use of protective equipment | |||
| treatment = [[Corticosteroids]], [[immunosuppressive therapy]] | |||
| prognosis = Variable, can lead to chronic lung disease | |||
| frequency = Rare, primarily in occupational settings | |||
}} | |||
[[File:Granuloma.jpg|left|thumb|Granuloma.jpg]] '''Beryllium granuloma''' is a type of [[granuloma]] that forms in response to exposure to [[beryllium]], a chemical element with the symbol Be and atomic number 4. This condition is a manifestation of [[berylliosis]], also known as chronic beryllium disease (CBD), which is a chronic allergic-type lung response and chronic lung disease caused by exposure to beryllium and its compounds. | |||
==Pathophysiology== | ==Pathophysiology== | ||
Beryllium granulomas are formed as a result of the body's immune response to beryllium particles. When beryllium is inhaled, it can be deposited in the [[lungs]] and other tissues. The immune system recognizes beryllium as a foreign substance and mounts an immune response. This involves the activation of [[T cells]], which release cytokines that attract other immune cells to the site of beryllium deposition. These immune cells form a granuloma, which is a small area of inflammation. | Beryllium granulomas are formed as a result of the body's immune response to beryllium particles. When beryllium is inhaled, it can be deposited in the [[lungs]] and other tissues. The immune system recognizes beryllium as a foreign substance and mounts an immune response. This involves the activation of [[T cells]], which release cytokines that attract other immune cells to the site of beryllium deposition. These immune cells form a granuloma, which is a small area of inflammation. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
Patients with beryllium granulomas may present with symptoms similar to those of other granulomatous diseases, such as [[sarcoidosis]]. Common symptoms include: | Patients with beryllium granulomas may present with symptoms similar to those of other granulomatous diseases, such as [[sarcoidosis]]. Common symptoms include: | ||
| Line 10: | Line 27: | ||
* [[Chest pain]] | * [[Chest pain]] | ||
* [[Fatigue]] | * [[Fatigue]] | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of beryllium granuloma typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. Key diagnostic tools include: | The diagnosis of beryllium granuloma typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. Key diagnostic tools include: | ||
| Line 16: | Line 32: | ||
* [[Beryllium lymphocyte proliferation test]] (BeLPT) to detect beryllium sensitivity. | * [[Beryllium lymphocyte proliferation test]] (BeLPT) to detect beryllium sensitivity. | ||
* [[Biopsy]] of affected tissue to confirm the presence of granulomas and to rule out other causes. | * [[Biopsy]] of affected tissue to confirm the presence of granulomas and to rule out other causes. | ||
==Treatment== | ==Treatment== | ||
There is no cure for beryllium granuloma, but treatment focuses on managing symptoms and preventing further exposure to beryllium. Treatment options may include: | There is no cure for beryllium granuloma, but treatment focuses on managing symptoms and preventing further exposure to beryllium. Treatment options may include: | ||
| Line 22: | Line 37: | ||
* [[Immunosuppressive drugs]] in severe cases. | * [[Immunosuppressive drugs]] in severe cases. | ||
* Avoidance of further beryllium exposure to prevent disease progression. | * Avoidance of further beryllium exposure to prevent disease progression. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with beryllium granuloma varies. Some individuals may experience mild symptoms and stable disease, while others may develop progressive lung disease leading to significant impairment. | The prognosis for individuals with beryllium granuloma varies. Some individuals may experience mild symptoms and stable disease, while others may develop progressive lung disease leading to significant impairment. | ||
==Prevention== | ==Prevention== | ||
Preventing beryllium granuloma involves minimizing exposure to beryllium, particularly in occupational settings. This can be achieved through: | Preventing beryllium granuloma involves minimizing exposure to beryllium, particularly in occupational settings. This can be achieved through: | ||
| Line 31: | Line 44: | ||
* Implementation of safety protocols. | * Implementation of safety protocols. | ||
* Regular monitoring of beryllium levels in the workplace. | * Regular monitoring of beryllium levels in the workplace. | ||
==See also== | ==See also== | ||
* [[Berylliosis]] | * [[Berylliosis]] | ||
| Line 37: | Line 49: | ||
* [[Occupational lung disease]] | * [[Occupational lung disease]] | ||
* [[Sarcoidosis]] | * [[Sarcoidosis]] | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
==External links== | ==External links== | ||
{{Commons category|Beryllium}} | {{Commons category|Beryllium}} | ||
{{Wiktionary|beryllium}} | {{Wiktionary|beryllium}} | ||
[[Category:Occupational diseases]] | [[Category:Occupational diseases]] | ||
[[Category:Respiratory diseases]] | [[Category:Respiratory diseases]] | ||
[[Category:Immune system disorders]] | [[Category:Immune system disorders]] | ||
[[Category:Inflammatory diseases]] | [[Category:Inflammatory diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 19:21, 4 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Beryllium granuloma | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Cough, shortness of breath, fatigue |
| Complications | Chronic beryllium disease, pulmonary fibrosis |
| Onset | Variable, often years after exposure |
| Duration | Chronic |
| Types | N/A |
| Causes | Exposure to beryllium |
| Risks | Occupational exposure in industries such as aerospace, nuclear power, and electronics |
| Diagnosis | Chest X-ray, CT scan, lung biopsy, beryllium lymphocyte proliferation test |
| Differential diagnosis | Sarcoidosis, tuberculosis, hypersensitivity pneumonitis |
| Prevention | Avoidance of beryllium exposure, use of protective equipment |
| Treatment | Corticosteroids, immunosuppressive therapy |
| Medication | N/A |
| Prognosis | Variable, can lead to chronic lung disease |
| Frequency | Rare, primarily in occupational settings |
| Deaths | N/A |

Beryllium granuloma is a type of granuloma that forms in response to exposure to beryllium, a chemical element with the symbol Be and atomic number 4. This condition is a manifestation of berylliosis, also known as chronic beryllium disease (CBD), which is a chronic allergic-type lung response and chronic lung disease caused by exposure to beryllium and its compounds.
Pathophysiology[edit]
Beryllium granulomas are formed as a result of the body's immune response to beryllium particles. When beryllium is inhaled, it can be deposited in the lungs and other tissues. The immune system recognizes beryllium as a foreign substance and mounts an immune response. This involves the activation of T cells, which release cytokines that attract other immune cells to the site of beryllium deposition. These immune cells form a granuloma, which is a small area of inflammation.
Clinical Presentation[edit]
Patients with beryllium granulomas may present with symptoms similar to those of other granulomatous diseases, such as sarcoidosis. Common symptoms include:
Diagnosis[edit]
The diagnosis of beryllium granuloma typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. Key diagnostic tools include:
- Chest X-ray or CT scan to identify granulomas in the lungs.
- Beryllium lymphocyte proliferation test (BeLPT) to detect beryllium sensitivity.
- Biopsy of affected tissue to confirm the presence of granulomas and to rule out other causes.
Treatment[edit]
There is no cure for beryllium granuloma, but treatment focuses on managing symptoms and preventing further exposure to beryllium. Treatment options may include:
- Corticosteroids to reduce inflammation.
- Immunosuppressive drugs in severe cases.
- Avoidance of further beryllium exposure to prevent disease progression.
Prognosis[edit]
The prognosis for individuals with beryllium granuloma varies. Some individuals may experience mild symptoms and stable disease, while others may develop progressive lung disease leading to significant impairment.
Prevention[edit]
Preventing beryllium granuloma involves minimizing exposure to beryllium, particularly in occupational settings. This can be achieved through:
- Use of protective equipment.
- Implementation of safety protocols.
- Regular monitoring of beryllium levels in the workplace.
See also[edit]
References[edit]
<references group="" responsive="1"></references>
External links[edit]
